Dr. Matthew Mao Zhang, MD

Dr. Zhang practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Zhang's NPI, 1760748792, was assigned on April 3, 2012. Dr. Zhang graduated from University of Pittsburgh School of Medicine in 2012. Dr. Zhang holds Washington license MD60852446.

Dr. Zhang's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Zhang's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Zhang is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Zhang to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zhang is licensed in Washington.

CMS data shows 403 Medicare services from Dr. Zhang across 7 procedure codes in 2024, for 191 Medicare patients. Medicare paid $28,042 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 85 patients. 60% of them have high cholesterol, and 59% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 64, with 59% women.

In 2024, Dr. Zhang wrote 47 Medicare Part D claims for 20 patients. 49% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $963 in total drug cost. In 2022, CMS named 59 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Zhang for performance year 2024, reported through an alternative payment model (APM). Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Zhang, published from 2021 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Anti-Bacterial Agents, Endoscopy and Eyelids. Dr. Zhang has published most often in Orbit. Dr. Zhang's most frequent co-authors are Christopher Bayard Chambers, MD, Tejus Pradeep, MD and Colin Froines, MD.

CMS Open Payments shows 6 general payments to Dr. Zhang from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $238.

Dr. Zhang graduated from University of Pittsburgh School of Medicine in 2012.